A Dose-Response Study of Ibogaine-Induced Neuropathology in the Rat Cerebellum
Mechanisms Preclinical moderate
AI-extracted · unverified · confirm at source
Ibogaine ip NOAEL 25 mg/kg in female rats. Purkinje cell degeneration dose-dependent: 0/6 at 25, 2/6 at 50, 6/6 at 75–100 mg/kg. GFAP most sensitive biomarker.
Contraindications: Pre-existing cerebellar pathology